(Q34274920)

1 August 2017

title

Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG. (English)

1 reference

1 August 2017

Todd A Triplett

1

1 reference

1 August 2017

Brendan D Curti

2

1 reference

1 August 2017

Peter R Bonafede

3

1 reference

1 August 2017

William L Miller

4

1 reference

1 August 2017

Edwin B Walker

5

1 reference

1 August 2017

Andrew D Weinberg

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

European Journal of Immunology

1 August 2017

published in

1 reference

1 August 2017

volume

42

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

1893-1905

1 reference

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

The biology of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Control of CD4+ T-cell memory by cytokines and costimulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Efficient internalization of IL-2 depends on the distal portion of the cytoplasmic tail of the IL-2R common gamma-chain and a lymphoid cell environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

The proteasome regulates receptor-mediated endocytosis of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Tolerance, not immunity, crucially depends on IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

A function for interleukin 2 in Foxp3-expressing regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

CD25 Appears Non Essential for Human Peripheral Treg Maintenance In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

IL-2 receptor alpha deficiency and features of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Development and homeostasis of T cell memory in rhesus macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Nonredundant roles for Stat5a/b in directly regulating Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3- T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

7 January 2021

Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

7 January 2021

Human IL-2 receptor alpha chain deficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

7 January 2021

CD4+CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

7 January 2021

CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242444

7 January 2021

Identifiers

DOI

10.1002/EJI.201242444

1 reference

1 August 2017

1 reference